Table 1.
Baseline patient characteristics of both the full patient population as well as the matched-pair analysis. No significant differences were identified between the SARS-CoV2 Alpha variant group and the SARS-CoV2 wild-type group. #: matching criteria (sex, age).
| Full Patient Population (n = 160) | Matched-Pair Analysis (n = 116) | |||||
|---|---|---|---|---|---|---|
| Alpha Variant (n = 80) | Wild Type (n = 80) | p | Alpha Variant (n = 58) | Wild Type (n = 58) | p | |
| Age (median, range) | 55.5 (13–83) | 62.5 (16–87) | 0.073 | 61 (26–83) # | 62 (25–85) # | 0.917 |
| Males | 59/80 (74%) | 57/80 (71%) | 0.860 | 43/58 (74.1%) # | 43/58 (74.1%) # | 1 |
| Diabetes | 25/80 (26%) | 21/80 (31%) | 0.601 | 20/58 (34.5%) | 14/58 (24.1%) | 0.308 |
| Chronic respiratory diseases | 13/80 (16%) | 10/80 (13%) | 0.653 | 9/58 (15.5%) | 4/58 (6.9%) | 0.238 |
| Cardiovascular disease | 44/80 (55%) | 40/80 (50%) | 0.635 | 30/58 (51.7%) | 30/58 (51.7%) | 1 |
| Oncologic/hematologic disease/immunosuppressive medication | 11/80 (14%) | 16/80 (20%) | 0.399 | 9/58 (15.5%) | 12/58 (20.7%) | 0.630 |
| Liver disease | 8/80 (10%) | 4/80 (5%) | 0.369 | 5/58 (8.6%) | 3/58 (5.2%) | 0.717 |